Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice. 1996

M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
Rhône-Poulenc Rorer, S.A., Centre de Recherche de Vitry-Alfortville, Vitry Sur Seine, France.

UI MeSH Term Description Entries
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D000077146 Irinotecan A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin,CPT 11,CPT-11,Camptosar,Camptothecin-11,Irinotecan Hydrochloride,Irrinotecan,NK012 Compound,SN 38,SN 38 11,SN-38,SN-38-11,7 Ethyl 10 hydroxycamptothecin,CPT11,Camptothecin 11,SN3811
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
August 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
February 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
July 1998, International journal of urology : official journal of the Japanese Urological Association,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
January 1991, Cancer chemotherapy and pharmacology,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
January 2012, PloS one,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
April 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
December 2005, Cancer chemotherapy and pharmacology,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
April 2000, Drug metabolism and disposition: the biological fate of chemicals,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
April 1999, International journal of hematology,
M C Bissery, and P Vrignaud, and F Lavelle, and G G Chabot
November 2006, Anti-cancer drugs,
Copied contents to your clipboard!